Kathleen Carey1, Jake R Morgan2, Meng-Yun Lin3, Michael S Kain4, William R Creevy4. 1. Department of Health Law, Policy and Management, Boston University School of Public Health, Boston, MA. 2. Boston University School of Medicine, Section of Infectious Disease, Boston, MA. 3. Boston University School of Medicine, Section of General Internal Medicine, Boston, MA. 4. Boston Medical Center, Department of Orthopedic Surgery, One Boston Medical Center Place, Boston, MA.
Abstract
BACKGROUND: For several years, many orthopedic surgeons have been performing total joint replacements in hospital outpatient departments (HOPDs) and more recently in ambulatory surgery centers (ASCs). In a recent shift, the Centers for Medicare and Medicaid Services began reimbursing for total knee replacement surgery in HOPDs. Some observers have expressed concerns over patient safety for the Medicare population particularly if Centers for Medicare and Medicaid Services extends the policy to include total hip replacement surgery and coverage in ASCs. METHODS: This study used a large claims database of non-Medicare patients to examine inpatient and outpatient total knee replacement and total hip replacement surgery performed on a near-elderly population during 2014-2016. We applied propensity score methods to match inpatients with ASC patients and HOPD patients with ASC patients adjusting for risk using the HHS Hierarchical Condition Categories risk adjustment model. We conducted statistical tests comparing clinical outcomes across the 3 settings and examined relative costs. RESULTS: Readmissions, postsurgical complications, and payments were lower for outpatients than for inpatients. Within outpatient settings, readmissions and postsurgical complications were lower in ASCs than in HOPDs but payments for ASC patients were higher than payments for HOPD patients. CONCLUSION: Our findings support the argument that outpatient total joint replacement is appropriate for select patients treated in both HOPDs and ASCs, although in the commercially insured population, the latter services may come at a cost. Until further study of outpatient total joint replacement in the Medicare population becomes available, how this will extrapolate to the Medicare population is unknown.
BACKGROUND: For several years, many orthopedic surgeons have been performing total joint replacements in hospital outpatient departments (HOPDs) and more recently in ambulatory surgery centers (ASCs). In a recent shift, the Centers for Medicare and Medicaid Services began reimbursing for total knee replacement surgery in HOPDs. Some observers have expressed concerns over patient safety for the Medicare population particularly if Centers for Medicare and Medicaid Services extends the policy to include total hip replacement surgery and coverage in ASCs. METHODS: This study used a large claims database of non-Medicare patients to examine inpatient and outpatient total knee replacement and total hip replacement surgery performed on a near-elderly population during 2014-2016. We applied propensity score methods to match inpatients with ASCpatients and HOPD patients with ASCpatients adjusting for risk using the HHS Hierarchical Condition Categories risk adjustment model. We conducted statistical tests comparing clinical outcomes across the 3 settings and examined relative costs. RESULTS: Readmissions, postsurgical complications, and payments were lower for outpatients than for inpatients. Within outpatient settings, readmissions and postsurgical complications were lower in ASCs than in HOPDs but payments for ASCpatients were higher than payments for HOPD patients. CONCLUSION: Our findings support the argument that outpatient total joint replacement is appropriate for select patients treated in both HOPDs and ASCs, although in the commercially insured population, the latter services may come at a cost. Until further study of outpatient total joint replacement in the Medicare population becomes available, how this will extrapolate to the Medicare population is unknown.
Authors: Matthew T Kingery; Germaine E Cuff; Lorraine H Hutzler; Jovan Popovic; Roy I Davidovitch; Joseph A Bosco Journal: J Arthroplasty Date: 2017-08-08 Impact factor: 4.757
Authors: Richard A Berger; Sharat K Kusuma; Sheila A Sanders; Elizabeth S Thill; Scott M Sporer Journal: Clin Orthop Relat Res Date: 2009-02-24 Impact factor: 4.176
Authors: Steven M Kurtz; Edmund C Lau; Kevin L Ong; Edward M Adler; Frank R Kolisek; Michael T Manley Journal: J Arthroplasty Date: 2016-04-04 Impact factor: 4.757
Authors: Frank R Kolisek; Mike S McGrath; Nenette M Jessup; Eric A Monesmith; Michael A Mont Journal: Clin Orthop Relat Res Date: 2009-02-18 Impact factor: 4.176
Authors: Scott T Lovald; Kevin L Ong; Arthur L Malkani; Edmund C Lau; Jordana K Schmier; Steven M Kurtz; Michael T Manley Journal: J Arthroplasty Date: 2013-08-21 Impact factor: 4.757
Authors: Ritesh R Shah; Nancy E Cipparrone; Alexander C Gordon; David J Raab; James R Bresch; Nishant A Shah Journal: Arthroplast Today Date: 2018-09-22
Authors: Chimere O Ezuma; Yining Lu; Ayoosh Pareek; Ryan Wilbur; Aaron J Krych; Brian Forsythe; Christopher L Camp Journal: Arthrosc Sports Med Rehabil Date: 2022-05-24
Authors: Y F L Bemelmans; M H F Keulen; M Heymans; E H van Haaren; B Boonen; M G M Schotanus Journal: Arch Orthop Trauma Surg Date: 2021-02-15 Impact factor: 2.928